Clinical study on targeted extracellular matrix denatured collagen molecular probe

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500115328

Enrollment

Unknown

Registered

2025-12-24

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

68Ga-CHP-04:Injection of Molecular Probe 68Ga-CHP-04

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old, male or female not limited; 2.Research participants have behavioral capacity, understand and have voluntarily signed informed consent forms; 3.Patients with newly diagnosed malignant tumors or previously diagnosed diseases undergoing concurrent treatment.

Exclusion criteria

Exclusion criteria: 1.Critically ill patients requiring emergency treatment; 2.Drug and/or alcohol abusers, individuals with allergies; 3.Pregnant, lactating, and pre pregnancy women.

Design outcomes

Primary

Measure	Time frame
Maximum Standardized Uptake Value;	—

Countries

China

Contacts

Public ContactFu Wei

Affiliated Hospital of Guilin Medical University

13977385850@126.com+86 139 7738 5850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026